Back to today’s briefing

Story perspectives

Novo Nordisk and Valo Health Join Forces for $4.6B Health Initiative

1/17/2025

27 6

Summary

Story summary

Novo Nordisk and Valo Health have deepened their partnership, now valued at an impressive $4.6 billion, to tackle type 2 diabetes, obesity, and cardiovascular disease. This collaboration harnesses Valo's cutting-edge AI technology for drug discovery and seeks to boost clinical trial participation in Korea, thanks to a new alliance with Seoul National University Bundang Hospital.

1 of 1

Story summary

Novo Nordisk and Valo Health have deepened their partnership, now valued at an impressive $4.6 billion, to tackle type 2 diabetes, obesity, and cardiovascular disease. This collaboration harnesses Valo's cutting-edge AI technology for drug discovery and seeks to boost clinical trial participation in Korea, thanks to a new alliance with Seoul National University Bundang Hospital.